Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray
出版年份 2015 全文链接
标题
Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of gray
作者
关键词
-
出版物
Immunotherapy
Volume 7, Issue 2, Pages 163-174
出版商
Future Medicine Ltd
发表日期
2015-02-25
DOI
10.2217/imt.14.104
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
- (2014) Sefina Arif et al. DIABETES
- GAD Autoantibody Affinity in Adult Patients With Latent Autoimmune Diabetes, the Study Participants of a GAD65 Vaccination Trial
- (2014) Stephanie Krause et al. DIABETES CARE
- Immune modulation in humans: implications for type 1 diabetes mellitus
- (2014) Bart O. Roep et al. Nature Reviews Endocrinology
- Progress in immune-based therapies for type 1 diabetes
- (2013) M. von Herrath et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Anti-CD3 clinical trials in type 1 diabetes mellitus
- (2013) Anastasia G. Daifotis et al. CLINICAL IMMUNOLOGY
- Infectious Tolerance as Candidate Therapy for Type 1 Diabetes: Transfer of Immunoregulatory Properties from Human Regulatory T Cells to Other T Cells and Proinflammatory Dendritic Cells
- (2013) Fleur S. Kleijwegt et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Multiple HLA Epitopes Contribute to Type 1 Diabetes Susceptibility
- (2013) C. L. Roark et al. DIABETES
- Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
- (2013) J. M. Sosenko et al. DIABETES
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protege Trial
- (2013) W. Hagopian et al. DIABETES
- Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment
- (2013) Tihamer Orban et al. DIABETES CARE
- GAD-treatment of children and adolescents with recent-onset type 1 diabetes preserves residual insulin secretion after 30 months
- (2013) Johnny Ludvigsson et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Seroconversion to Multiple Islet Autoantibodies and Risk of Progression to Diabetes in Children
- (2013) Anette G. Ziegler et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- Immune intervention therapy in type 1 diabetes: safety first
- (2013) Bart O Roep Lancet Diabetes & Endocrinology
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
- (2012) Teodora P. Staeva et al. DIABETES
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
- (2012) C. J. Greenbaum et al. DIABETES
- Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
- (2012) Ken T. Coppieters et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The problems and promises of research into human immunology and autoimmune disease
- (2012) Bart O Roep et al. NATURE MEDICINE
- GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
- (2012) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct
- (2011) J. M. M. Howson et al. DIABETES
- Contribution of Antibodies Against IA-2β and Zinc Transporter 8 to Classification of Diabetes Diagnosed Under 40 Years of Age
- (2011) Ilse Vermeulen et al. DIABETES CARE
- Persistence of Individual Variations in Glycated Hemoglobin: Analysis of data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial
- (2011) D. M. Wilson et al. DIABETES CARE
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial
- (2011) Diane K Wherrett et al. LANCET
- Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial
- (2011) Nicole Sherry et al. LANCET
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial
- (2011) Tihamer Orban et al. LANCET
- Immunological efficacy of heat shock protein 60 peptide DiaPep277TM therapy in clinical type I diabetes
- (2010) V. A. L. Huurman et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
- (2010) J. B. Matthews et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Extended evaluation of the safety and efficacy of GAD treatment of children and adolescents with recent-onset type 1 diabetes: a randomised controlled trial
- (2010) J. Ludvigsson et al. DIABETOLOGIA
- Dietary Intervention in Infancy and Later Signs of Beta-Cell Autoimmunity
- (2010) Mikael Knip et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes
- (2009) Jeffrey C Barrett et al. NATURE GENETICS
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial
- (2008) Kirsti Näntö-Salonen et al. LANCET
- GAD Treatment and Insulin Secretion in Recent-Onset Type 1 Diabetes
- (2008) Johnny Ludvigsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation
- (2008) Volkert A. L. Huurman et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started